Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Laurus Labs Ltd (LAUL)
Assess today's live Laurus Labs Ltd (LAUL) share price, performance and insights using our live NSE: LAUL stock exchange data.
Analyse the historical data and Laurus Labs Ltd share price performance charts on this page. Our technical summary section provides analysis on Laurus Labs share price buy/sell indicators using real-time data (or discuss the Laurus Labs (LAUL) stock price today with other investors in the Laurus Labs NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE LAUL share price (ISIN: INE947Q01028) to enhance your trading decisions with our free investment tools and resources.
What Is the Laurus Labs Ltd Share Price Today?
The Laurus Labs share price today is 980.30.
What Is the Stock Symbol for Laurus Labs Ltd
The stock symbol (or 'ticker') for Laurus Labs Ltd is "LAUL."
What Stock Exchange Does Laurus Labs Ltd Trade On?
Laurus Labs Ltd is listed and trades on the NSE stock exchange.
Is Laurus Labs Ltd a Good Stock to Buy?
Determining whether Laurus Labs Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Laurus Labs Ltd share price performance charts on this page. Our technical summary section provides analysis on Laurus Labs share price buy/sell indicators using real-time data (or discuss the Laurus Labs (LAUL) stock price today with other investors in the Laurus Labs NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE LAUL share price (ISIN: INE947Q01028) to enhance your trading decisions with our free investment tools and resources.
What Is the Laurus Labs Ltd Share Price Today?
The Laurus Labs share price today is 980.30.
What Is the Stock Symbol for Laurus Labs Ltd
The stock symbol (or 'ticker') for Laurus Labs Ltd is "LAUL."
What Stock Exchange Does Laurus Labs Ltd Trade On?
Laurus Labs Ltd is listed and trades on the NSE stock exchange.
Is Laurus Labs Ltd a Good Stock to Buy?
Determining whether Laurus Labs Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
980.30
+4.70(+0.48%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
971.05
995.00
52 wk Range
512.35
1,141.00
LAUL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
971.05995.00
52 wk Range
512.351,141.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.16%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.16%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
LAUL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
913.47
Downside
-6.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
- Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Laurus Labs Company Profile
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Compare LAUL to Peers and Sector
Metrics to compare | LAUL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLAULPeersSector | |
|---|---|---|---|---|
P/E Ratio | 62.5x | 36.4x | −0.6x | |
PEG Ratio | 0.19 | 0.77 | 0.00 | |
Price/Book | 11.0x | 4.4x | 2.6x | |
Price / LTM Sales | 7.8x | 4.3x | 3.3x | |
Upside (Analyst Target) | −0.1% | 13.7% | 45.0% | |
Fair Value Upside | Unlock | 1.4% | 6.5% | Unlock |
Analyst Ratings
5 Buy
3 Hold
7 Sell
Ratings:
15 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 913.47
(-6.82% Downside)
Earnings
Latest Release
Jan 23, 2026
EPS / Forecast
4.70 / 3.61
Revenue / Forecast
17.78B / 16.87B
People Also Watch
FAQ
What Is the Laurus Labs (LAUL) Share Price Today?
The live Laurus Labs share price today is 980.30
What Stock Exchange Does Laurus Labs (LAUL) Trade On?
Laurus Labs is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Laurus Labs?
The stock symbol (also called a 'ticker') for Laurus Labs is "LAUL."
Does Laurus Labs Pay Dividends? What’s The Current LAUL Dividend Yield?
Yes, LAUL Pays Dividends to its Shareholders. The current Laurus Labs dividend yield is 0.16%.
What Is the Current Laurus Labs Market Cap?
As of today, Laurus Labs market capitalisation is 529.22B.
What Is Laurus Labs's (LAUL) Earnings Per Share (TTM)?
The Laurus Labs EPS is currently 15.61 (Trailing Twelve Months).
When Is the Next Laurus Labs Earnings Date?
Laurus Labs's next earnings report will be released on 22 Apr 2026.
Is LAUL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Laurus Labs moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Laurus Labs Stock Split?
Laurus Labs has split 1 times. (See the LAUL stock split history page for full effective split date and price information.)
How Many Employees Does Laurus Labs Have?
Laurus Labs has 6167 employees.
What is the current trading status of Laurus Labs (LAUL)?
As of 04 Feb 2026, Laurus Labs (LAUL) is trading at a price of 980.30, with a previous close of 975.60. The stock has fluctuated within a day range of 971.05 to 995.00, while its 52-week range spans from 512.35 to 1,141.00.
What Is Laurus Labs (LAUL) Price Target According to Analysts?
The average 12-month price target for Laurus Labs is INR913.47, with a high estimate of INR1230 and a low estimate of INR293. 5 analysts recommend buying the stock, while 7 suggest selling, leading to an overall rating of Neutral. The stock has an -6.82% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.